This Week in Virology: TWiV 1232: Clinical update with Dr. Daniel Griffin

interfluidity, subscribed podcasts

In his weekly clinical update, Dr. Griffin with Vincent Racaniello are shocked at how vaccine safety is undercut by misrepresenting thimerosal safety, its removal from vaccines, and how CBER director Vinay Prasad overruled his advisors for the administration of COVID vaccines to pregnant people knowingly compromising their health, before Dr. Griffin reviews recent statistics on measles epidemic, RSV, influenza and SARS-CoV-2 infections the Wasterwater Scan dashboard, whether or not the NB.1.8.1 should be included in the fall 2025 vaccines, immunization recommendations for COVID-19 vaccines, where to find PEMGARDA, provides information for Columbia University Irving Medical Center’s long COVID treatment center, where to go for answers to your long COVID questions, association of long COVID and cognitive changes as well as the development of type I diabetes and contacting your federal government representative to stop the assault on science and biomedical research.

Subscribe (free): Apple Podcasts, RSS, email

Become a patron of TWiV!

Links for this episode

• Thimerosal and Vaccines (FDA)
• Thimerosal-containing vaccines and neurodevelopmental outcomes (CDC)
• Thimerosal and Vaccines (CDC: Vaccine safety)
• WHO says ‘no evidence of harm’ from thimerosal (Reuters)
• RFK Jr.’s Vaccine Panel Has a New Approach: Question Everything (Wall Street Journal)
• COVID-19 infection poses higher risk for myocarditis than vaccines (American Heart Association)
• Top F.D.A. Official Overrode Scientists on Covid Shots (NY Times)
• Who Sets the Immunization Schedule? (CDC: Vaccines for your children)
• Recommended Child and Adolescent Immunization Schedule for ages 18 years or younger (CDC)
• H5 bird flu: current situation (CDC: Avian Influenza)
• Assessing the transmissibility and outbreak risk of measles in the United States, 2024 – 2030 (JID)
• Proof of a measles vaccine for travelers coming from various countries, including the United States (US Embassy in Honduras)
• More measles outbreaks put US total within single digits of modern-day record (CIDRAP)
• Epidemiological Update – Measles in the Americas Region – 1 July 2025 (PAHO)
• Wastewater for measles (WasterWater Scan)
• Measles cases and outbreaks (CDC Rubeola)
• New Mexico announces measles outbreak in a county detention facility (AP News)
• Weekly measles and rubella monitoring (Government of Canada)
• Measles vaccine recommendations from NYP (jpg)
• Measles (WHO)
• Get the FACTS about measles (NY State Department of Health)
• Measles (CDC Measles (Rubeola))
• Measles vaccine (CDC Measles (Rubeola))
• Presumptive evidence of measles immunity (CDC)
• Contraindications and precautions to measles vaccination (CDC)
• Adverse events associated with childhood vaccines: evidence bearing on causality (NLM)
• Measles Vaccination: Know the Facts(ISDA: Infectious Diseases Society of America)
• Deaths following vaccination: what does the evidence show (Vaccine)
• Influenza: Waste water scan for 11 pathogens (WastewaterSCan)
• US respiratory virus activity (CDC Respiratory Illnesses)
• Respiratory virus activity levels (CDC Respiratory Illnesses)
• Weekly surveillance report: clift notes (CDC FluView)
• Influenza Vaccination During Pregnancy and Infant Influenza in the First 6 Months of Life (Obstetrics & Gynecology)
• Influenza vaccination in Japanese children, 2024/25: Effectiveness of inactivated vaccine and limited use of newly introduced live-attenuated vaccine (Vaccine)
• FDA-CDC-DOD: 2025-2046 influenza vaccine composition (FDA)
• RSV: Waste water scan for 11 pathogens (WastewaterSCan)
• US respiratory virus activity (CDC Respiratory Illnesses)
• RSV-Network (CDC Respiratory Syncytial virus Infection)
• Novel Drug Approvals for 2025 (FDA)
• Waste water scan for 11 pathogens (WastewaterSCan)
• COVID-19 deaths (CDC)
• COVID-19 national and regional trends (CDC)
• Independent assessment of the origins of SARS‑CoV‑2(WHO)
• COVID-19 variant tracker (CDC)
• SARS-CoV-2 genomes galore (Nextstrain)
• Antigenic and Virological Characteristics of SARS-CoV-2 Variant BA.3.2, XFG, and NB.1.8.1 (bioRxiV)
• Estimated 2023-2024 COVID-19 Vaccine Effectiveness in Adults (JAMA)
• RECOVID: Retrospective Observational Study of Renal Outcomes and Long-Term Mortality in Patients With COVID-19-Associated AKI, A Comparison Between Vaccinated and Unvaccinated Patients (Kidney Medicine)
• Where to get pemgarda (Pemgarda)
• EUA for the pre-exposure prophylaxis of COVID-19 (INVIYD)
• Infusion center (Prime Fusions)
• CDC Quarantine guidelines (CDC)
• NIH COVID-19 treatment guidelines (NIH)
• Drug interaction checker (University of Liverpool)
• Infectious Disease Society guidelines for treatment and management (ID Society)
• Molnupiravir safety and efficacy (JMV)
• Convalescent plasma recommendation for immunocompromised (ID Society)
• What to do when sick with a respiratory virus (CDC)
• Managing healthcare staffing shortages (CDC)
• Steroids,dexamethasone at the right time (OFID)
• Anticoagulation guidelines (hematology.org)
• Daniel Griffin’s evidence based medical practices for long COVID (OFID)
• Long COVID hotline (Columbia : Columbia University Irving Medical Center)
• The answers: Long COVID
• COVID-19 and Cognitive Change in a Community-Based Cohort(JAMA)
• SARS-CoV-2 infection and new-onset type 1 diabetes in the post-acute period among children and young people in England(Diabetic Medicine) Reaching out to US house representative
• Letters read on TWiV 1232
• Dr. Griffin’s COVID treatment summary (pdf)
• Timestamps by Jolene Ramsey. Thanks!

Intro music is by Ronald Jenkees

Send your questions for Dr. Griffin to [email protected]

Content in this podcast should not be construed as medical advice.